Why this matters
Africa's scientists are ready. The systems are not.
By 2050, Africa will be home to one of the world's largest workforces. Yet many young scientists lack access to the training, equipment, and funding they need to turn their ideas into vaccines, diagnostics, therapies, and technologies that solve local health and development challenges.
Underfunded labs, fragmented infrastructure, and limited mentorship slow down discovery. Strategic, patient capital can change that — especially in high-impact areas like biotechnology, immunology, infectious disease, and advanced microscopy.
Gaps we are working to close
Limited access to modern research infrastructure and microscopy facilities.
Scarce funding for early-stage scientific ideas in biotechnology and immunology.
Weak bridges between universities, research institutes, industry, and policy.
Underrepresentation of African scientists in global research and decision-making.